U.S. Genomics Raises $4.5 Million

U.S. Genomics, a Woburn, Mass.-based developer of single-molecule biology technologies for diagnostics and biodefense applications, has raised $4.5 million in private equity funding from Becton, Dickinson & Co. The two companies also entered a strategic partnership to collaborate on the creation of an infectious disease diagnostic platform.

North AmericaUSBriefs